Opus Genetics (IRD) Q4 2024 Annual Earnings
IRD·Reported March 31, 2025·Before market open
Opus Genetics reported Q4 2024 revenue of $4.3M, beat analyst consensus of $3.4M by $913.5K. Diluted EPS came in at $-1.27, missed the $-0.34 consensus by $0.93.
Revenue
$4.3Mbeat by $913.5K
Consensus: $3.4MDiluted EPS
$-1.27missed by $0.93
Consensus: $-0.34
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Opus Genetics's Q4 2024 earnings report.
Opus Genetics (IRD) reported Q4 2024 earnings on March 31, 2025 before market open.
Opus Genetics reported revenue of $4.3M and diluted EPS of $-1.27 for Q4 2024.
Revenue beat the consensus estimate of $3.4M by $913.5K. EPS missed the consensus estimate of $-0.34 by $0.93.
You can read the 10-K periodic report (0001140361-25-011410) directly on SEC EDGAR. The filing index links above go to sec.gov.